Featured Speaker: Andrea Schmidts, Post Doctoral Research Fellow, MD Cellular Immunotherapy Program, MGH Cancer Center and Harvard Medical School
In this Webinar we discuss:
Discover how a trimeric extracellular moiety of APRIL has enhanced binding to BCMA and TACI compared with monomeric APRIL when incorporated into a CAR
Explore why trimeric APRIL-based CAR are efficient against BCMA-negative multiple myeloma
Learn why T cells transduced with a trimeric APRIL-based CAR are a promising approach for the treatment of multiple myeloma
Access related webinars, eBooks, app notes & case studies.